"I am thinking in terms of problem solving. Traditional commercial drug design and projects funding from the NIH has completely ignored this approach to date," stated Dr. Hershline. "I think we have to talk in terms of a cure for HIV. I want to cure HIV and that is why my foundation is called CureHIV.us," concluded Dr. Hershline.
Dr. Hershline is hopeful that the foundation community, including the Grand Challenges in Global Health initiative, looks into the work and progress that he has made towards solving this problem and fills the gap in funding.
Dr. Hershline has a doctorate degree in drug design and a medical degree. Pre-clinical development of LiSAVIOR has been twenty years in the making. Despite the critical need for such a unique and potentially lifesaving invention, LiSAVIOR remains completely un-funded.
Interested parties can contact Dr. Roger Kenneth Hershline, PhD, MD, thru CureHIV.us Headquarters by email: Roger@CureHIV.us, mail: P.O. Box 23467, Hilton Head Is., SC, 29925, fax: +1-843-342-5924, phone: +1-843-342-5900. Direct to Dr. Hershline: +1-843-683-3683.
Web site: http://www.curehiv.us
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
Copyright©2008 PR Newswire.
All rights reserved